Home > Income Statement > BIOCON

BIOCON
Consolidated Net Profit

    Back to Income Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹463 Cr₹648 Cr₹741 Cr₹748 Cr₹905 Cr

What is the latest Consolidated Net Profit of BIOCON ?

The latest Consolidated Net Profit ratio of BIOCON is ₹463 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹463 Cr
Mar2023₹648 Cr
Mar2022₹741 Cr
Mar2021₹748 Cr
Mar2020₹905 Cr

How is Consolidated Net Profit of BIOCON Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹463 Cr
-28.64
Mar2023 ₹648 Cr
-12.44
Mar2022 ₹741 Cr
-1.03
Mar2021 ₹748 Cr
-17.35
Mar2020 ₹905 Cr -

Compare Consolidated Net Profit of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹36,642.3 Cr -11.7% -8.5% 19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,394.0 Cr -6.7% 2.6% 5% Stock Analytics
DIVIS LABORATORIES ₹142,920.0 Cr -6.6% -3.7% 43.8% Stock Analytics
CIPLA ₹114,383.0 Cr -5.3% -2.9% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,817.0 Cr -3.8% 1.8% 25.8% Stock Analytics
DR REDDYS LABORATORIES ₹91,385.4 Cr -4.9% -3.3% -10.2% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-11.7%

-8.5%

19.1%

SENSEX

-3.6%

-0.7%

-0.5%


You may also like the below Video Courses